US 7388071
Composition and method for inducing and enhancing a telomerase reverse transcriptase-reactive cytotoxic T lymphocyte response
granted A61KA61K2239/49A61K2239/50
Quick answer
US patent 7388071 (Composition and method for inducing and enhancing a telomerase reverse transcriptase-reactive cytotoxic T lymphocyte response) held by The Regents of the University of California expires Mon Jun 12 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of California
- Grant date
- Tue Jun 17 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 12 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 5
- CPC classes
- A61K, A61K2239/49, A61K2239/50, A61K2239/55, A61K2239/57